3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
450
Stomach Neoplasms
295
Rectal Neoplasms
271
Colonic Neoplasms
192
Pancreatic Neoplasms
177
Neoplasm Metastasis
94
Esophageal Neoplasms
88
Carcinoma, Hepatocellular
60
Adenocarcinoma Of Esophagus
47
Cholangiocarcinoma
46
Neoplasms
42
Biliary Tract Neoplasms
38
Gallbladder Neoplasms
31
Adenocarcinoma
30
Gastrointestinal Neoplasms
29
Liver Neoplasms
25
Esophageal Squamous Cell Carcinoma
23
Carcinoma, Non-Small-Cell Lung
18
Bile Duct Neoplasms
17
Parkinson Disease 4, Autosomal Dominant Lewy Body
13
Locally Advanced Rectal Cancer
13
Colorectal Cancer Metastatic
11
Appendiceal Neoplasms
11
Recurrence
10
Peritoneal Neoplasms
10
Ovarian Neoplasms
9
Carcinoma
7
Breast Neoplasms
7
Neurotoxicity Syndromes
6
Gastrointestinal Diseases
6
Interventions
Oxaliplatin
1
Folfox protocol
1
Capecitabine
1
ASTX-660
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally-advanced Rectal Cancer
×
Oxaliplatin
×
Gastrointestinal
×
Clear all
NCT05912075
2024-02-08
PRAAR1
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
Recruiting
78 enrolled